Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
SAMDAILY.US - ISSUE OF MARCH 07, 2020 SAM #6673
SOLICITATION NOTICE

Q -- Sequelae and Immunopathology of Ebola Virus Infections

Notice Date
3/5/2020 3:47:54 PM
 
Notice Type
Presolicitation
 
NAICS
541690 — Other Scientific and Technical Consulting Services
 
Contracting Office
FDA OFFICE OF ACQ GRANT SVCS ROCKVILLE MD 20857 USA
 
ZIP Code
20857
 
Solicitation Number
FDA-RFP-20-1225983
 
Response Due
3/19/2020 7:00:00 AM
 
Archive Date
04/03/2020
 
Point of Contact
Robert Maydwell, Phone: 3013481814
 
E-Mail Address
Robert.Maydwell@fda.hhs.gov
(Robert.Maydwell@fda.hhs.gov)
 
Description
The current contract is a study focused on Sequelae and Immunopathology of Ebola Virus Infections.� This modification is necessary to respond to the ongoing 2019-nCoV virus (nCoV) outbreak and leverages the technology and methodology for examining Ebola sequelae and Zika immunopathology to extend analysis and gather critical information about the nature of nCoV virus infection. This work aims to characterize the effects of nCoV virus infection using samples from non-human primate (NHP) animal models and human tissues (pending availability) to empower future regulatory decision making. Stanford shall apply a set of technologies for high parameter antibody-based profiling of blood and tissues (CyTOF, CODEX) along with viral nucleic acid detection in situ (viralMIBI).
 
Web Link
SAM.gov Permalink
(https://beta.sam.gov/opp/c0db91de34bb42c4bec42c1f32191b82/view)
 
Place of Performance
Address: Philadelphia, PA 19104, USA
Zip Code: 19104
Country: USA
 
Record
SN05580635-F 20200307/200305230145 (samdaily.us)
 
Source
SAM.gov Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's SAM Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.